Evidence map›Paper›PMID 26856828›Full record

ArticleAntimicrobial agents and chemotherapy2016

Effects of Low-Dose Amoxicillin on Staphylococcus aureus USA300 Biofilms.

Kevin D Mlynek, Mary T Callahan, Anton V Shimkevitch, Jackson T Farmer, Jennifer L Endres, Mélodie Marchand, Kenneth W Bayles, Alexander R Horswill, Jeffrey B Kaplan

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Sub-inhibitory concentrations of ceftriaxone induce morphological alterations and PIA-independent biofilm formation in Staphylococcus aureus.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  10. Beyond the double helix: the multifaceted landscape of extracellular DNA inFrontiers in cellular and infection microbiology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Biofilm formation of two genetically diverseFrontiers in microbiology · 2023
    Article
  17. Sub-Inhibitory Concentrations of Amoxicillin and Tylosin Affect the Biofilm Formation and Virulence ofInternational journal of environmental research and public health · 2022
    Article
  18. Identification ofPathogens (Basel, Switzerland) · 2021
    Article
  19. A global transcriptomic analysis ofMicrobial genomics · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kevin D MlynekDepartment of Biology, American University, Washington, DC, USA.
Mary T CallahanDepartment of Biology, American University, Washington, DC, USA.
Anton V ShimkevitchDepartment of Biology, American University, Washington, DC, USA.
Jackson T FarmerDepartment of Biology, American University, Washington, DC, USA.
Jennifer L EndresDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Mélodie MarchandDepartment of Biology, American University, Washington, DC, USA.
Kenneth W BaylesDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Alexander R HorswillDepartment of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Jeffrey B KaplanDepartment of Biology, American University, Washington, DC, USA kaplanjb@american.edu.
University of Nebraska Medical Center · USAmerican University · USUniversity of Iowa · US

Funding

The S. aureus biofilm lifecycleP01AI083211 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BAYLES, KENNETH W. · 2009 to 2023
$32.1M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
Biofilm matrix-degrading enzymes for the treatment and prevention of S. aureus-asR01AI097182 · NIAID · UNIV OF MED/DENT OF NJ-NJ DENTAL SCHOOL · PI KAPLAN, JEFFREY B · 2012 to 2014
$511k
NIAID NIH HHS P01 AI083211NIAID NIH HHS R01 AI097182NIDDK NIH HHS P30 DK054759
6 · The paper itself

Abstract

Previous studies showed that sub-MIC levels of β-lactam antibiotics stimulate biofilm formation in most methicillin-resistant Staphylococcus aureus (MRSA) strains. Here, we investigated this process by measuring the effects of sub-MIC amoxicillin on biofilm formation by the epidemic community-associated MRSA strain USA300. We found that sub-MIC amoxicillin increased the ability of USA300 cells to attach to surfaces and form biofilms under both static and flow conditions. We also found that USA300 biofilms cultured in sub-MIC amoxicillin were thicker, contained more pillar and channel structures, and were less porous than biofilms cultured without antibiotic. Biofilm formation in sub-MIC amoxicillin correlated with the production of extracellular DNA (eDNA). However, eDNA released by amoxicillin-induced cell lysis alone was evidently not sufficient to stimulate biofilm. Sub-MIC levels of two other cell wall-active agents with different mechanisms of action-d-cycloserine and fosfomycin-also stimulated eDNA-dependent biofilm, suggesting that biofilm formation may be a mechanistic adaptation to cell wall stress. Screening a USA300 mariner transposon library for mutants deficient in biofilm formation in sub-MIC amoxicillin identified numerous known mediators of S. aureus β-lactam resistance and biofilm formation, as well as novel genes not previously associated with these phenotypes. Our results link cell wall stress and biofilm formation in MRSA and suggest that eDNA-dependent biofilm formation by strain USA300 in low-dose amoxicillin is an inducible phenotype that can be used to identify novel genes impacting MRSA β-lactam resistance and biofilm formation.

Indexed as

AmoxicillinAnti-Bacterial Agentsbeta-LactamsBiofilmsMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsStaphylococcus aureusAmoxicillinAnti-Bacterial Agentsbeta-Lactams

Identifiers

PMID26856828
PMCPMC4862544
OpenAlexW2315489536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.